Helixstreet.io is a decentralized blockchain infrastructure built for life sciences. We enable the proof of ownership and connection of genomic datasets, creating an immutable ledger where individuals and researchers can contribute and establish relationships between biological data with cryptographic certainty.
Our mission is to democratize genomic research through decentralization, allowing scientists and individuals to collaboratively advance drug development, disease research, and personalized medicine without surrendering data ownership or privacy.
The Helixstreet Foundation is headquartered near Zug, Switzerland, in the heart of Crypto Valley alongside the Cardano Foundation, Web3 Foundation, and Ethereum Foundation.
Our location in Zug provides access to world-class regulatory expertise, research institutions, and a vibrant ecosystem of blockchain and biotech companies. Switzerland's commitment to privacy, governance, and decentralization aligns perfectly with our values.
The Foundation brings together researchers, developers, and genomicists who share a vision of creating a more equitable, transparent, and decentralized approach to health data management.
Helixstreet operates as a decentralized foundation with multi-stakeholder governance. Researchers, participants, and the broader community have a voice in the direction of the protocol through on-chain governance mechanisms.
Our structure ensures that no single entity controls the network, and all decisions about protocol upgrades, fee structures, and research priorities are made transparently and collectively.
Helixstreet is built on Substrate, deployed as a Polkadot parathread, inheriting security from the Polkadot relay chain.
Leveraging the robust Substrate framework and Polkadot's shared security model to provide a scalable, secure blockchain optimized for life sciences applications.
Zero-knowledge proofs enable provable claims about genetic relatedness and data ownership without revealing sensitive DNA information or personal health data.
Cross-Consensus Messaging allows other chains and metaverse projects to access and integrate genomic data and ancestry relationships securely.
Purpose-built pallets for handling VCF files, proteomic datasets, and complex biological relationships with specialized indexing and query optimization.
Cryptographic proofs establish irrefutable ownership claims over genomic sequences and allow immutable recording of data provenance and contribution history.
Optimized consensus mechanisms and pruning strategies ensure the chain remains light enough for researchers to run full nodes and participate in validation.
Helixgroups are decentralized communities of individuals with shared genetic traits, health conditions, or research interests. These groups collaborate to advance drug development, establish safety baselines, and contribute to medical research without intermediaries.
By pooling genetic and health data under transparent, consensus-based governance, helixgroups can accelerate disease research, improve pharmaceutical trials, and enable discoveries that benefit millions.
Each group member retains complete ownership and control over their data, with fine-grained permissions managing who can access, analyze, or reference their genetic information.
Helixstreet employs a dual-validation model where all data connections require explicit consent from both contributing parties and approval from decentralized governance.
Every proposed connection between genomic datasets must be validated by both data providers. This cryptographic consent mechanism ensures that relationships are established only with explicit permission from all parties involved.
The protocol records all consent events immutably, creating an auditable trail of who approved what data connections at what time.
Protocol changes, fee structures, and research priorities are governed through on-chain voting where token holders and community members participate in decision-making.
Governance decisions are enforced automatically through smart contracts, eliminating the need for trusted intermediaries and ensuring transparency in all protocol changes.
Helixstreet's development unfolds in coordinated phases, from core protocol launch through ecosystem maturation and advanced research enablement.
Launch Substrate parathread on Polkadot testnet. Implement core genomic data ownership pallets, ZK-SNARK proof systems, and on-chain governance framework. Establish Helixstreet Foundation and initial advisory board.
Mainnet launch with dual-validation consensus. Integrate with early research partners and enable HelixGroups formation. Implement XCM bridges to metaverse platforms. Deploy open-source explorer and wallet integrations.
Expand HelixGroups for drug development and clinical trials. Enable proteomics and metabolomics datasets on-chain. Launch research grants program and university partnerships. Develop advanced query languages for complex genetic analysis.
Enable full multi-chain interoperability with derivative chains. Implement advanced privacy-preserving computation for on-chain analysis. Establish Helixstreet as foundational health data layer for Web3 health applications.
No single entity controls genomic data or research outcomes. All governance decisions are made collectively through transparent on-chain mechanisms.
Individuals retain complete ownership and control of their genomic information. Permission and access rights are granted explicitly and can be revoked at any time.
Helixstreet advances scientific knowledge through transparent, collaborative research. Discoveries benefit the entire community, not proprietary interests.
Every design decision prioritizes patient welfare and accelerates the discovery of treatments and cures for genetic diseases and conditions.
Helixstreet is available globally to researchers, patients, and participants. No geographic or economic barriers limit participation in health research.
We commit to ensuring that the benefits of genomic research are distributed fairly and that historically marginalized groups have voice in data governance.